Update 2020: management of non-small cell lung cancer
M Alexander, SY Kim, H Cheng - Lung, 2020 - Springer
The past decade has seen a revolution of new advances in the management of non-small
cell lung cancer (NSCLC) with remarkable progresses in screening, diagnosis, and …
cell lung cancer (NSCLC) with remarkable progresses in screening, diagnosis, and …
[HTML][HTML] Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies
Background Patients with coronavirus disease 2019 (COVID-19) who have underlying
malignancy have a higher mortality rate compared with those without cancer, although the …
malignancy have a higher mortality rate compared with those without cancer, although the …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study
E Merzon, D Tworowski, A Gorohovski… - The FEBS …, 2020 - Wiley Online Library
Vitamin D deficiency is a worldwide pandemic. The aim of this study was to evaluate
associations of plasma 25 (OH) D levels with the likelihood of coronavirus disease 2019 …
associations of plasma 25 (OH) D levels with the likelihood of coronavirus disease 2019 …
[HTML][HTML] Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer …
Background Patients with cancer may be at high risk of adverse outcomes from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Abstract Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer
Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …
patients with cancer and COVID-19 has become critically important. Objective To compare …
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta …
Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …
COVID-19 and cancer: current challenges and perspectives
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
effect has included the adverse outcomes in patients with cancer who develop COVID-19 …
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (January 2021)
Background Accurate molecular diagnostic tests are necessary for confirming a diagnosis of
coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory …
coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory …